 |
|
Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
Soo-Kyung Park, Sang-Bum Kang, SangSoo Kim, Tae Oh Kim, Jae Myung Cha, Jong Pil Im, Chang Hwan Choi, Eun Soo Kim, Geom Seog Seo, Chang Soo Eun, Dong Soo Han, Dong Il Park
Korean J Intern Med. 2022;37(5):949-957. Published online 2022 Mar 31 DOI: https://doi.org/10.3904/kjim.2021.458
|
|
Citations to this article as recorded by
 Additive efficacy and safety of probiotics in the treatment of ulcerative colitis: a systematic review and meta-analysis
Xinyue Wang, Chunyu Zhou, Shaohui Zhang, Yixiang Ma, Wenqin Xiao, Yanmei Guo
European Journal of Nutrition.2024; 63(5): 1395. CrossRef Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta‐analysis of randomized controlled trials
Maria Manuela Estevinho, Yuhong Yuan, Iago Rodríguez‐Lago, Mário Sousa‐Pimenta, Cláudia Camila Dias, Manuel Barreiro‐de Acosta, Vipul Jairath, Fernando Magro
United European Gastroenterology Journal.2024; 12(7): 960. CrossRef A Mini Literature Review of Probiotics: Transforming Gastrointestinal Health Through Evidence-Based Insights
Cara Mohammed, Jhon P Fuego, Karina V Garcia, Hira Jamil, Rahul Y Rajesh, Andres S Escobar, Muhammad J Hassan, Manju Rai
Cureus.2024;[Epub] CrossRef Probiotics for inflammatory bowel disease: Is there sufficient evidence?
Yueying Ma, Dandan Yang, Jin Huang, Kunli Liu, Huirong Liu, Huangan Wu, Chunhui Bao
Open Life Sciences.2024;[Epub] CrossRef
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing
Escherichia coli
Nissle 1917 strain
Luca Falzone, Alessandro Lavoro, Saverio Candido, Mario Salmeri, Antonino Zanghì, Massimo Libra
Gut Microbes.2024;[Epub] CrossRef Bacterial live therapeutics for human diseases
Elisabet Frutos-Grilo, Yamile Ana, Javier Gonzalez-de Miguel, Marcel Cardona-i-Collado, Irene Rodriguez-Arce, Luis Serrano
Molecular Systems Biology.2024;[Epub] CrossRef Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis
Tao Zhang, Xiaoang Li, Jun Li, Feng Sun, Liping Duan
Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef Bifidobacterium: a probiotic for the prevention and treatment of depression
Jiayu Li, Junyu Wang, Meiyu Wang, Li Zheng, Qiuyu Cen, Fangfang Wang, Li Zhu, Rizhao Pang, Anren Zhang
Frontiers in Microbiology.2023;[Epub] CrossRef Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022
Cuilan Huang, Wujuan Hao, Xuyang Wang, Renmin Zhou, Qiong Lin
Frontiers in Microbiology.2023;[Epub] CrossRef Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Catherine O’Reilly, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, R. Paul Ross
Microbiome Research Reports.2023;[Epub] CrossRef Genetically engineered bacteria: a new frontier in targeted drug delivery
Saba Fooladi, Navid Rabiee, Siavash Iravani
Journal of Materials Chemistry B.2023; 11(42): 10072. CrossRef Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives
Raz Abdulqadir, Jessica Engers, Rana Al-Sadi
Current Developments in Nutrition.2023; 7(12): 102026. CrossRef Delivery of E. coli Nissle to the mouse gut by mucoadhesive microcontainers does not improve its competitive ability against strains linked to ulcerative colitis
Pi Westi Bondegaard, Anders Meyer Torp, Priscila Guerra, Katja Ann Kristensen, Juliane Fjelrad Christfort, Karen Angeliki Krogfelt, Line Hagner Nielsen, Kinga Zor, Anja Boisen, Martin Steen Mortensen, Martin Iain Bahl, Tine Rask Licht
FEMS Microbiology Letters.2023;[Epub] CrossRef
|